tiprankstipranks
Trending News
More News >
Aspire Biopharma Holdings (ASBP)
NASDAQ:ASBP
US Market

Aspire Biopharma Holdings (ASBP) Income Statement

Compare
34 Followers

Aspire Biopharma Holdings Income Statement

Last quarter (Q3 2024), Aspire Biopharma Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Aspire Biopharma Holdings's net income was $-243.63K. See Aspire Biopharma Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 1.34M$ 976.35K$ 25.48K
Depreciation and Amortization
$ 1.34M$ 976.35K$ 27.79K
EBITDA
$ 5.80M$ 4.32M$ -25.48K
Operating Income
$ -1.34M$ -5.29M$ -25.48K
Other Income/Expenses
$ 5.80M$ 4.32M$ 5.00
Pretax Income
$ 4.46M$ 3.34M$ -25.48K
Net Income
$ 4.46M$ 7.66M$ -25.48K
Per Share Metrics
Basic EPS
$ 0.23$ 0.21$ 0.00
Diluted EPS
$ 0.23$ 0.21$ 0.00
Weighted Average Shares Outstanding
19.18M 35.94M 6.25M
Weighted Average Shares Outstanding (Diluted)
19.18M 35.94M 6.25M
Currency in USD

Aspire Biopharma Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis